CClinicalTrials.gg
Status unknownNCT04677582VALÉUpdated Dec 21, 2020

VALÉ: A Multidisciplinary Childhood Obesity Treatment Program for Latino Communities

An interventional study of Vidas Activas, famiLias saludablEs (VALE) in Pediatric Obesity, sponsored by George Mason University. Status unknown at 2 sites in United States. Open to participants aged 5 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-12-21.

Sponsored by George Mason University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2020), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Oct 2017, registered Aug 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Not applicable
Ages
5 Years to 11 Years
Sex
All
01

Study summary

This proposal aims to test the initial feasibility and efficacy of a 10-week multidisciplinary pediatric weight management program among low-income Latino children, aged 5 to 11 years, from the Woodbridge, VA area. The following specific aims will be tested:

Read the detailed description

Specific Aim 1: To test the acceptability of a multidisciplinary group intervention targeted towards low-income Latino families with a child who is obese.

Specific Aim 2: To test the effectiveness of the intervention by determining differences in behavioral changes (i.e. nutrition and physical activity habits), anthropometric (BMI-for-age, body fat) and clinical health outcomes (i.e. blood pressure, blood biomarkers) between children exposed to the intervention program vs. control children.

02

Conditions studied

  • Pediatric Obesity
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's planned enrollment of 140 is above the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

George Mason University is the lead sponsor of 41 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Pre-pubertal (girls must not have started menses)
  • Of Latino/Hispanic descent (parent self-identified)
  • BMI for age >85th percentile (based on CDC growth reference)
  • Child between 5-11 years old
  • Healthy (no known chronic diseases or regular medication)
  • Parent/adult caregivers willing to participate in all study visits

Exclusion criteria

Exclusion Criteria:

  • Not of Latino/Hispanic descent
  • \<5 years old or >11 years old
  • BMI for age \<85th percentile
  • Not pre-pubertal (girls have experienced their first menses)
  • Child has learning deficits or acute/chronic medical condition
  • Parent/guardian has no transportation or unable to participate in sessions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    The intervention group will receive weekly education sessions about nutrition, exercise, and behavioral health.

    Behavioral: Vidas Activas, famiLias saludablEs (VALE)

Interventions

  • BehavioralVidas Activas, famiLias saludablEs (VALE)

    Families and Children allocated to the intervention will receive weekly group-based meetings over a 10-week period consisting of education and activities on healthy lifestyles. Graduate students/Research Assistants trained in nutrition, exercise and clinical psychology will lead the meetings. All activities will be culturally relevant (i.e. cooking healthy Latino recipes) and Spanish speaking students will be recruited to deliver the intervention. Participants will be involved on deciding activities and projects and while some sessions will meet as a family group with parents/guardians, others will meet separately.

06

What researchers measure

Primary outcomes

  1. Change from Baseline BMI at 3 months and 6 months

    body weight (kg)/height(m\^2)

    Time frame: Baseline, 3 and 6 months

  2. Change from Baseline Body Fat Percentage at 3 months and 6 months

    % via bioelectric impedance

    Time frame: Baseline, 3 and 6 months

  3. Change from Baseline Blood Pressure at 3 months and 6 months

    Systolic \& Diastolic Blood Pressure

    Time frame: Baseline, 3 and 6 months

  4. Change from Baseline Waist Circumference at 3 months and 6 months

    cm

    Time frame: Baseline, 3 and 6 months

  5. Change from Baseline HbA1c at 3 months and 6 months

    HbA1c (%)

    Time frame: Baseline, 3 and 6 months

  6. Change from Baseline Glucose at 3 months and 6 months

    Glucose (mg/dL)

    Time frame: Baseline, 3 and 6 months

  7. Change from Baseline Blood Lipids at 3 months and 6 months

    LDL, HDL, TRG, TC (mg/dL)

    Time frame: Baseline, 3 and 6 months

07

Study locations

2 sites
  • Featherstone Elementary School
    Woodbridge, Virginia 22191, United States
  • Kilby Elementary School
    Woodbridge, Virginia 22191, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 21, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04677582
Lead sponsor
George Mason University
Responsible party
Sponsor
First posted
Dec 21, 2020
Start date
Oct 4, 2017
Primary completion
Jun 20, 2021 (estimated)
Completion
Jul 2021 (estimated)
Last update
Dec 21, 2020

Study contacts

Margaret Jones, PhD, CSCS*D
principal investigator · George Mason University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion